Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Fatigue
ADR ID BADD_A01626
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.002      Fatigue
Description A disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activities. [CTCAE] The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. [MeSH]
MedDRA Code 10016256
MeSH ID D005221; D005221; D005221
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Enervation | Exhaustion | Exhaustion due to excessive exertion | Exhaustion due to exposure | Fatigability | Fatigability generalized | Fatigability lumbar | Fatigability of knees | Fatigue | Fatigue extreme | Fatiguability | Lassitude | Loss physical strength | Prostration | TATT | Tired all the time | Tired and heavy | Tired out | Tiredness | Washed-out | Weariness | Worn out | Fatigue aggravated | Depressive weariness | Fatigueability generalised | Chronic fatigue | Fatiguability generalised
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Epidermal growth factor receptorP00533T59328
Receptor tyrosine-protein kinase erbB-2P04626T14597
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02457Dexmethylphenidate--
BADD_D02459Dalteparin--
BADD_D02461Lanreotide0.070570%
BADD_D02464Fingolimod0.716213%
BADD_D02465Aclidinium--
BADD_D02467Naloxegol--
BADD_D02468Cannabidiol0.007099%
BADD_D02470Nintedanib0.020514%
BADD_D02471Oxygen--
BADD_D02472Sonidegib0.001598%
BADD_D02473Sodium chloride--
BADD_D02476Polyethylene glycol--
BADD_D02477Tenofovir alafenamide0.016636%
BADD_D02480Alectinib0.005062%
BADD_D02482Acalabrutinib0.001332%
BADD_D02483Ribociclib0.022112%
BADD_D02484Istradefylline0.008286%
BADD_D02485Talazoparib0.001598%
BADD_D02486Niraparib0.032236%
BADD_D02487Baricitinib--
BADD_D02488Esketamine--
BADD_D02489Neratinib0.045823%
BADD_D02490Apalutamide0.051484%
BADD_D02491Valbenazine0.128102%
BADD_D02492Deflazacort--
BADD_D02495Duvelisib0.001598%
BADD_D02496Elagolix--
BADD_D02497Avatrombopag0.006534%
BADD_D02498Abemaciclib0.023977%
BADD_D02500Alpelisib0.007992%
The 41th Page    First    Pre   41 42    Next   Last    Total 42 Pages